CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade OpGen, Inc. - OPGN CFD

    0.38
    2.56%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.05
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.39
    Open* 0.4
    1-Year Change* 2.56%
    Day's Range* 0.38 - 0.4
    52 wk Range 0.16-1.70
    Average Volume (10 days) 289.99K
    Average Volume (3 months) 6.97M
    Market Cap 10.36M
    P/E Ratio -100.00K
    Shares Outstanding 53.70M
    Revenue 3.31M
    EPS -0.91
    Dividend (Yield %) N/A
    Beta -0.25
    Next Earnings Date Mar 27, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 0.38 -0.02 -5.00% 0.40 0.40 0.38
    Dec 7, 2023 0.39 -0.01 -2.50% 0.40 0.40 0.39
    Dec 6, 2023 0.40 0.01 2.56% 0.39 0.41 0.39
    Dec 5, 2023 0.40 0.00 0.00% 0.40 0.41 0.40
    Dec 4, 2023 0.40 0.02 5.26% 0.38 0.43 0.38
    Dec 1, 2023 0.39 0.00 0.00% 0.39 0.42 0.39
    Nov 30, 2023 0.39 -0.02 -4.88% 0.41 0.41 0.39
    Nov 29, 2023 0.41 0.01 2.50% 0.40 0.44 0.40
    Nov 28, 2023 0.42 -0.01 -2.33% 0.43 0.43 0.41
    Nov 27, 2023 0.44 0.01 2.33% 0.43 0.45 0.43
    Nov 24, 2023 0.43 0.01 2.38% 0.42 0.43 0.41
    Nov 22, 2023 0.40 -0.02 -4.76% 0.42 0.42 0.40
    Nov 21, 2023 0.39 -0.03 -7.14% 0.42 0.42 0.39
    Nov 20, 2023 0.43 0.00 0.00% 0.43 0.43 0.42
    Nov 17, 2023 0.42 0.00 0.00% 0.42 0.43 0.40
    Nov 16, 2023 0.42 -0.01 -2.33% 0.43 0.44 0.40
    Nov 15, 2023 0.42 -0.04 -8.70% 0.46 0.46 0.42
    Nov 14, 2023 0.47 -0.02 -4.08% 0.49 0.49 0.47
    Nov 13, 2023 0.48 -0.01 -2.04% 0.49 0.49 0.46
    Nov 10, 2023 0.49 -0.04 -7.55% 0.53 0.53 0.48

    OpGen, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 4.30603 4.21444 3.49861 2.94631 3.21101
    Revenue 4.30603 4.21444 3.49861 2.94631 3.21101
    Cost of Revenue, Total 2.84845 3.84849 1.63172 1.84844 2.13318
    Gross Profit 1.45758 0.36595 1.86689 1.09787 1.07783
    Total Operating Expense 27.3197 26.048 15.7699 16.1266 18.4768
    Selling/General/Admin. Expenses, Total 13.6492 11.8958 7.71716 8.60087 9.46033
    Research & Development 10.9107 9.96472 5.12117 5.67724 6.88329
    Unusual Expense (Income) -0.08864 0.33899 1.29981
    Operating Income -23.0137 -21.8335 -12.2712 -13.1802 -15.2658
    Interest Income (Expense), Net Non-Operating -3.99266 -4.24493 -0.26009 -0.18787 -0.15353
    Net Income Before Taxes -34.7619 -26.0784 -12.4465 -13.3681 -15.4193
    Net Income After Taxes -34.8057 -26.2108 -12.4465 -13.3681 -15.4193
    Net Income Before Extra. Items -34.8057 -26.2108 -12.4465 -13.3681 -15.4193
    Net Income -34.8057 -26.2108 -12.4465 -13.3681 -15.4193
    Total Adjustments to Net Income -7.16675 0
    Income Available to Common Excl. Extra. Items -41.9725 -26.2108 -12.4465 -13.3681 -15.4193
    Income Available to Common Incl. Extra. Items -41.9725 -26.2108 -12.4465 -13.3681 -15.4193
    Diluted Net Income -41.9725 -26.2108 -12.4465 -13.3681 -15.4193
    Diluted Weighted Average Shares 36.6741 15.8008 1.61694 0.30045 0.07869
    Diluted EPS Excluding Extraordinary Items -1.14447 -1.65883 -7.69754 -44.4931 -195.954
    Diluted Normalized EPS -1.14604 -1.64489 -6.89367 -44.4931 -195.954
    Other, Net -7.75554 0.08488
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total revenue 0.46975 1.42557 1.23913 0.81162 0.82972
    Revenue 0.46975 1.42557 1.23913 0.81162 0.82972
    Cost of Revenue, Total 0.32256 0.85728 0.85161 0.48051 0.65904
    Gross Profit 0.14719 0.56829 0.38752 0.33111 0.17068
    Total Operating Expense 6.31549 7.21229 6.32572 6.69077 7.09093
    Selling/General/Admin. Expenses, Total 3.67649 3.49971 3.0918 3.4948 3.56291
    Research & Development 2.31644 2.8553 2.3823 2.85959 2.81349
    Unusual Expense (Income) 0 0 0 -0.14414 0.0555
    Operating Income -5.84574 -5.78672 -5.08659 -5.87915 -6.26121
    Interest Income (Expense), Net Non-Operating -0.95798 -0.98131 -0.97012 -1.20741 -0.83382
    Other, Net 0 0 0 -7.75554
    Net Income Before Taxes -6.80372 -6.76804 -6.0567 -7.08656 -14.8506
    Net Income After Taxes -6.80372 -6.81186 -6.0567 -7.08656 -14.8506
    Net Income Before Extra. Items -6.80372 -6.81186 -6.0567 -7.08656 -14.8506
    Net Income -6.80372 -6.81186 -6.0567 -7.08656 -14.8506
    Income Available to Common Excl. Extra. Items -6.80372 -13.9786 -6.0567 -7.08656 -14.8506
    Income Available to Common Incl. Extra. Items -6.80372 -13.9786 -6.0567 -7.08656 -14.8506
    Diluted Net Income -6.80372 -13.9786 -6.0567 -7.08656 -14.8506
    Diluted Weighted Average Shares 46.4837 40.5761 38.2702 38.2683 29.4851
    Diluted EPS Excluding Extraordinary Items -0.14637 -0.3445 -0.15826 -0.18518 -0.50366
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.14637 -0.3445 -0.15826 -0.18895 -0.50178
    Total Adjustments to Net Income -7.16675
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 39.7426 16.8876 6.6673 5.78301 3.50178
    Cash and Short Term Investments 36.0804 13.3605 2.70822 4.57249 1.84717
    Cash & Equivalents 36.0804 13.3605 2.70822 4.57249 1.84717
    Total Receivables, Net 1.1724 0.6531 3.08929 0.37386 0.80954
    Accounts Receivable - Trade, Net 1.1724 0.6531 0.56781 0.37386 0.80954
    Total Inventory 1.23946 1.48599 0.47303 0.54375 0.53343
    Prepaid Expenses 1.25033 1.38809 0.39676 0.29292 0.31164
    Total Assets 71.6665 49.751 10.4218 8.95036 6.61991
    Property/Plant/Equipment, Total - Net 5.91661 5.79142 2.13289 1.22183 0.83554
    Goodwill, Net 7.45301 8.02473 0.60081 0.60081 0.60081
    Intangibles, Net 14.5302 16.581 0.81755 1.08537 1.35318
    Other Long Term Assets, Total 4.02413 2.4663 0.20327 0.25935 0.3286
    Total Current Liabilities 19.9168 7.37203 4.93854 4.38111 4.78959
    Accounts Payable 1.30708 1.86867 1.05604 1.62375 1.69171
    Accrued Expenses 4.04743 4.52809 2.92007 1.94359 1.90764
    Notes Payable/Short Term Debt 0 0 0 0 1.01096
    Current Port. of LT Debt/Capital Leases 14.5623 0.96547 0.95263 0.79794 0.15484
    Other Current Liabilities, Total 0 0.00981 0.00981 0.01582 0.02444
    Total Liabilities 30.4494 28.5598 6.12849 5.64162 5.21892
    Total Long Term Debt 7.1799 19.4257 0.64272 1.09753 0.13015
    Long Term Debt 7.17625 19.3789 0.32946 0.66034
    Capital Lease Obligations 0.00364 0.04679 0.31326 0.43719 0.13015
    Other Liabilities, Total 3.35279 1.76203 0.54723 0.16299 0.29917
    Total Equity 41.2171 21.1913 4.29334 3.30874 1.401
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.4645 0.25086 0.05582 0.08646 0.02265
    Additional Paid-In Capital 275.708 219.129 178.78 165.314 150.115
    Retained Earnings (Accumulated Deficit) -235.542 -200.736 -174.525 -162.079 -148.71
    Other Equity, Total 0.58563 2.54718 -0.01732 -0.01309 -0.0259
    Total Liabilities & Shareholders’ Equity 71.6665 49.751 10.4218 8.95036 6.61991
    Total Common Shares Outstanding 46.4502 25.0855 5.58228 0.43229 0.11327
    Property/Plant/Equipment, Total - Gross 9.45464 12.5538 8.15953 7.79614
    Accumulated Depreciation, Total -3.53803 -6.76234 -6.02664 -6.57431
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 33.4927 39.7426 29.7803 35.0704 42.7735
    Cash and Short Term Investments 30.6534 36.0804 25.3523 31.1824 39.3974
    Cash & Equivalents 30.6534 36.0804 25.3523 31.1824 39.3974
    Total Receivables, Net 0.26589 1.1724 0.75107 0.47257 0.48598
    Accounts Receivable - Trade, Net 0.26589 1.1724 0.75107 0.47257 0.48598
    Total Inventory 1.36122 1.23946 1.35691 1.33388 1.41744
    Prepaid Expenses 1.2122 1.25033 2.31994 2.08155 1.47267
    Total Assets 64.2594 71.6665 62.2889 68.5624 75.1556
    Property/Plant/Equipment, Total - Net 5.47882 5.91661 6.31662 6.48844 6.37178
    Goodwill, Net 7.31688 7.45301 7.60607 7.7906 7.6944
    Intangibles, Net 14.0542 14.5302 15.0504 15.6623 15.6566
    Other Long Term Assets, Total 3.91685 4.02413 3.53559 3.55063 2.65924
    Total Current Liabilities 19.0129 19.9168 19.1665 4.85727 6.5732
    Accounts Payable 0.86544 1.30708 1.1469 1.20711 1.24946
    Accrued Expenses 3.72615 4.04743 3.28233 3.53333 4.84834
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 14.4213 14.5623 14.7373 0.11683 0.46559
    Other Current Liabilities, Total 0 0 0.00981
    Total Liabilities 30.0883 30.4494 28.9901 28.8264 29.1243
    Total Long Term Debt 7.95829 7.1799 6.49217 20.6896 19.4599
    Long Term Debt 7.95548 7.17625 6.4843 20.6709 19.4306
    Capital Lease Obligations 0.0028 0.00364 0.00787 0.01869 0.02927
    Other Liabilities, Total 3.11714 3.35279 3.33142 3.27954 3.09121
    Total Equity 34.1711 41.2171 33.2989 39.7359 46.0313
    Common Stock 0.46558 0.4645 0.3827 0.3827 0.38267
    Additional Paid-In Capital 275.949 275.708 260.245 260.028 259.766
    Retained Earnings (Accumulated Deficit) -242.345 -235.542 -228.73 -222.673 -215.586
    Other Equity, Total 0.10178 0.58563 1.40083 1.99835 1.4687
    Total Liabilities & Shareholders’ Equity 64.2594 71.6665 62.2889 68.5624 75.1556
    Total Common Shares Outstanding 46.5578 46.4502 38.2702 38.2702 38.2665
    Preferred Stock - Non Redeemable, Net 0 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -34.8057 -26.2108 -12.4465 -13.3681 -15.4193
    Cash From Operating Activities -21.4793 -23.3965 -11.5054 -11.074 -14.3039
    Cash From Operating Activities 2.71391 2.33474 0.92138 0.73088 0.66909
    Deferred Taxes
    Non-Cash Items 12.664 2.21088 0.89515 0.98244 1.03856
    Cash Interest Paid 0.8952 0.95205 0.18736 0.05739 0.04821
    Changes in Working Capital -2.05144 -1.73131 -0.87551 0.58077 -0.59222
    Cash From Investing Activities -1.98361 -1.06351 -2.50258 -0.13733 -0.27695
    Capital Expenditures -1.98361 -0.13035 -0.03183 -0.14777 -0.27695
    Other Investing Cash Flow Items, Total -0.93315 -2.47075 0.01044
    Cash From Financing Activities 47.4514 34.0872 12.1681 13.8451 12.3482
    Issuance (Retirement) of Stock, Net 48.159 33.793 4.78251 0.59774 3.88537
    Issuance (Retirement) of Debt, Net -0.70755 0.2941 7.38564 13.2474 8.46282
    Foreign Exchange Effects -1.46361 1.58654 -0.00374 0.01288 -0.03752
    Net Change in Cash 22.5249 11.2136 -1.8436 2.64666 -2.27015
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -6.80372 -34.8057 -27.9939 -21.9371 -14.8506
    Cash From Operating Activities -5.0414 -21.4793 -17.6904 -12.5592 -4.96593
    Cash From Operating Activities 0.51427 2.71391 2.10732 1.29014 0.54691
    Non-Cash Items 1.22372 12.664 11.4256 10.1669 9.04202
    Cash Interest Paid 0.00112 0.8952 0.8868 0.88837 0.02603
    Changes in Working Capital 0.02433 -2.05144 -3.2295 -2.07908 0.29573
    Cash From Investing Activities -0.03871 -1.98361 -1.82477 -1.72306 -0.85089
    Capital Expenditures -0.03871 -1.98361 -1.82477 -1.72306 -0.85089
    Cash From Financing Activities -0.01753 47.4514 32.0374 32.2051 32.305
    Issuance (Retirement) of Stock, Net 0 48.159 32.8239 32.8239 32.8239
    Issuance (Retirement) of Debt, Net -0.01753 -0.70755 -0.67764 -0.61882 -0.51884
    Foreign Exchange Effects -0.41309 -1.46361 -0.72748 -0.2964 -0.629
    Net Change in Cash -5.51074 22.5249 11.7948 17.6264 25.8592
    Other Investing Cash Flow Items, Total 0
    Financing Cash Flow Items -0.10879

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    OpGen, Inc. Company profile

    OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company''s products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen; and QuickFISH and PNA FISH diagnostic test products for the identification of various infectious pathogens, as well as SARS CoV-2 test kits. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics, which combines clinical lab test results with patient and hospital information to provide analytics and insights to enable manage MDROs in the hospital and patient care environment; Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers; and ARES Technology Platform, including ARESdb, which provides next generation sequencing based and artificial intelligence powered, cloud-based bioinformatics solutions to generate AMR profiles, as well as predict antimicrobial susceptibility test results. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is based in Rockville, Maryland.
    Industry: Biotechnology & Medical Research (NEC)

    9717 Key West Avenue
    Suite 100
    20850

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,004.85 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    US100

    16,080.90 Price
    +0.500% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    XRP/USD

    0.67 Price
    -0.380% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading